Wednesday, February 10, 2010, 2:27am EST - Canadian Markets open in 7 hours and 3 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

ACTIVE BIOTECH (ACTI.ST)

 On Feb 9: 107.50 SEK  Up 2.00 (1.90%)  
MORE ON ACTI.ST
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ACTIVE BIOTECH (Stockholm:ACTI.ST) Delayed quote dataEdit
Last Trade: 107.50 SEK
Trade Time: Feb 9
Change: Up 2.00 (1.90%)
Prev Close: 107.50
Open: 105.50
Bid: 108.00
Ask: 108.50
1y Target Est: N/A
Day's Range: 102.00 - 108.00
52wk Range: 32.90 - 134.75
Volume: 45,934
Avg Vol (3m): 141,343
Market Cap: N/A
P/E (ttm): N/A
EPS (ttm): N/A
Div & Yield: N/A (N/A%)
ACTIVE BIOTECH (ACTI.ST)
1d  5d  3m  6m  1y  2y  5y  max 
 Add ACTI.ST to Portfolio   Download Data

HEADLINES
• Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions
Business Wire (Mon, Feb 8)
• Primary endpoint reached in Active Biotech's TASQ Phase II clinical trial in prostate cancer patients
Marketwire (Mon, Dec 14)
• Active Biotech's election committee appointed
Marketwire (Thu, Nov 5)
• Active Biotech AB Interim Report, January - September 2009
Marketwire (Thu, Nov 5)
• RhuDex Clinical Development to Continue Following Feedback from Regulatory Authorities
Marketwire (Mon, Oct 5)
• Active Biotech to Present at the UBS Global Life Sciences Conference
Marketwire (Thu, Sep 17)
• Laquinimod presentations at ECTRIMS
Marketwire (Tue, Sep 8)
• Active Biotech to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
Marketwire (Fri, Sep 4)
• New information regarding RhuDex(TM)
Marketwire (Fri, Aug 7)
• Active Biotech AB Interim report January-June 2009
Marketwire (Thu, Aug 6)
More Headlines for ACTI.ST...
BUSINESS SUMMARY
No business summary available for ACTI.ST.


Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices